These are top 10 stocks traded on the Robinhood UK platform in July
On Friday, Oppenheimer analysts maintained their Outperform rating and $43.00 price target for ARAMARK Holdings (NYSE:ARMK), expressing confidence in the company's ability to navigate through potential economic challenges. This aligns with the broader analyst consensus, as InvestingPro data shows analyst targets ranging from $40 to $49, suggesting significant upside potential. The company's overall financial health is rated as "GOOD" by InvestingPro's comprehensive scoring system. The analysts highlighted ARAMARK's strong presence in stable U.S. markets, such as Education, Healthcare, Corrections, and Facilities, which contribute approximately 60% of the company's revenue. This domestic focus is seen as a significant advantage, with around 85% of U.S. food products sourced nationally, potentially mitigating the impact of tariffs and trade uncertainties. Recent InvestingPro data shows the company generated $17.5 billion in revenue over the last twelve months, with a 5.8% growth rate. Additionally, ARAMARK has maintained dividend payments for 12 consecutive years, demonstrating consistent shareholder returns.
The resilience of ARAMARK's business model was underscored by its performance during the Global Financial Crisis (GFC), where sales only experienced a low single-digit percentage drop, primarily due to its Business & Industry (B&I) segment, which represents 13% of revenues. The analysts pointed out that management has indicated that tariffs could increase costs by about 30 basis points, but this could be offset by actions such as leveraging Avendra Group Purchasing Organizations (GPO) benefits and the company's cost-plus and profit and loss (P&L) contract structures.
Moreover, Oppenheimer's analysis suggests that as long as inflation remains in the mid-single digits, ARAMARK is capable of passing through costs within a quarter on average. This ability to adjust to inflationary pressures is a key factor in the analysts' positive outlook.
In terms of valuation, ARAMARK's stock is currently trading at approximately 10 times the forecasted FY25 Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) and 9.3 times the FY26E EBITDA. This compares favorably to the Consumer Packaged Goods - Global Benchmark (CPG-GB), which trades at about 13.4 times and 12.3 times the forward-year average EBITDA, respectively. The five-year forward-year average EBITDA multiple for ARAMARK is around 11.5 times, further indicating a potential undervaluation in the eyes of Oppenheimer analysts.
In other recent news, Aramark has announced a series of strategic financial moves aimed at managing its debt and enhancing its financial stability. The company has issued €400 million in senior unsecured notes with a 4.375% interest rate, maturing in 2033. The proceeds from these notes will be used to repay existing €325 million senior notes due in 2025, with the remainder allocated for general corporate purposes. In addition, Aramark secured a $1.395 billion term loan, known as the U.S. Term B-8 Loans, which will be used to refinance existing loans and redeem 5.000% senior notes due in 2025.
Citi analyst Leo Carrington recently increased the price target for Aramark shares to $49, maintaining a Buy rating. This adjustment reflects changes in the financial model due to foreign exchange impacts and a revised projection for Adjusted Operating Income. Despite a slight decrease in the second-quarter AOI forecast, Carrington remains optimistic about Aramark's growth outlook, supported by outsourcing trends and recent contract wins. The analyst also noted that fiscal year 2025 and 2026 earnings per share estimates have been slightly increased due to FX considerations.
These developments highlight Aramark's proactive approach to managing its capital structure and addressing upcoming financial obligations. The company's financial maneuvers, including the issuance of new notes and securing a term loan, aim to maintain its net leverage and ensure long-term financial health. Investors and market analysts are closely monitoring these actions as part of Aramark's broader strategy to optimize its financial operations.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.